<DOC>
	<DOCNO>NCT01573949</DOCNO>
	<brief_summary>The Ahmanson-UCLA Cardiomyopathy Center conduct clinical research study ass use medication metformin improve quality life , exercise capacity , improve outcome heart failure patient pre-DM early DM ( type II ) . If patient participates study , patient receive drug metformin approximately 3 month . During study patient undergo comprehensive test include blood draw echocardiogram . The patient also fill questionnaire . The patient must 18 year old participate .</brief_summary>
	<brief_title>A Pilot Study : Metformin Therapy Heart Failure Patients With Early Diabetes High Risk Developing Diabetes ( Pre-Diabetes )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>symptomatic HF etiology age ≥ 18 year fast blood sugar equal great 100 mg/dL , preDM ( HbA1c 5.7 6.4 % ) early DM ( HbA1c ≥ 6.5 % ) current metformin therapy antidiabetic therapy previous intolerance metformin therapy renal dysfunction ( Cr &gt; 1.5 men &gt; 1.4 woman creatinine clearance &lt; 60 ml/minute ) history lactic acidosis current planned pregnancy breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Pre-diabetes</keyword>
	<keyword>Early type II diabetes</keyword>
	<keyword>Metformin</keyword>
	<keyword>Pharmacotherapy metformin prevention DM HF patient pre-diabetes ( pre-DM ) glycemic control HF patient early type II DM</keyword>
</DOC>